Article Details

Pfizer's Paxlovid antiviral drug does not reduce risk of long Covid: Study - indica News

Retrieved on: 2024-01-06 19:39:41

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's Paxlovid antiviral drug does not reduce risk of long Covid: Study - indica News. View article details on hiswai:

Excerpt

US pharma giant Pfizer's antiviral drug Paxlovid (Nirmatrelvir-ritonavir) does not reduce the risk of developing long Covid for vaccinated, ...

Article found on: indicanews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up